A Real-World Study of Pirtobrutinib in cBTKi-Resistant/Intolerant Mature B-Cell Lymphoma

Clinical trial NCT07525817 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07525817
Sponsor: Ou Bai, MD/PHD
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Mature B-Cell Lymphoma

Start date: 2026-04-01
Primary completion: 2028-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.